Stay updated on COR388 for AD: Phase 2/3 Clinical Trial

Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:13:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This appears to be a minor backend/version update with no visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-02-13T03:16:09.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, indicating a minor maintenance update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:16:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary display option and updated QC/versioning labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older label 'Last Update Submitted that met QC Criteria', the data label 'No FEAR Act data', and the older 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-29T06:17:12.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision banner updated to v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:56:04.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Study Details page adds a comprehensive list of trial locations by state and country (Arizona, California, Florida, Georgia, Idaho, Illinois, Kansas, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Virginia, Washington, Wisconsin; Cedex; Gipuzkoa; Birmingham; London; Science Park; UK) and replaces older location blocks with an updated geography (Revision: v3.3.3).
    Difference
    2%
    Check dated 2025-12-24T11:19:15.000Z thumbnail image

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.